Florida Biomedical Research Programs 2011 Annual Reports Available

The Florida Department of Health Office of Public Health Research is pleased to present the Florida Biomedical Research Programs' 2011 Annual Reports. The James and Esther King Biomedical Research Program and the Bankhead-Coley Cancer Research Program offer grants through merit-based competitions to eligible Florida scientists conducting research into tobacco-related diseases and cancer.

Florida Department of Health, Office of Public Health Research Announces a Public Meeting

The Office of Public Health Research announces a public meeting of the Florida Biomedical Research Advisory Council. The meeting will take place on January 25, 2012 in Jacksonville, Florida.

GRANTEE SPOTLIGHT: New Team Works to Improve Cure Rates in Head and Neck Cancer

Dr. W. Jarrard Goodwin, head and neck cancer (HNC) surgeon at Sylvester Cancer Center, is Project Director of a Bankhead-Coley 2009 Grant that represents an unprecedented partnership between researchers and physicians in Florida to treat and understand cancers associated with the throat and mouth.

GRANTEE SPOTLIGHT: Bringing New Understanding to the Treatment of Lung Cancer

Lung cancer is the #1 cause of cancer-related death in Florida, and an estimated 17,150 Florida patients will receive a new diagnosis of lung and bronchus cancer this year.

Research!America Florida Poll: Research Important for State Economy, Jobs

Floridians say State Must be a Leader in Science and Research

WASHINGTON—October 27, 2011—A majority of Floridians (87%) believe it is important for their state to be a leader in science and medical research, according to a new state poll commissioned by Research!America.

NEWS RELEASE: FIRST HEALTH DISPARITIES RESEARCH AGENDA FOR FLORIDA DEVELOPED

TALLAHASSEE – State Surgeon General Dr. Frank Farmer today applauds the development of Florida’s first Health Disparities Research Agenda. The Agenda was created by a partnership with the Florida Department of Health’s (DOH’s) Office of Minority Health, the Florida Center for Universal Research to Eradicate Disease (FL CURED), and the Biomedical Research Advisory Council (BRAC) in coordination with 31 of the state’s top health disparities researchers and outlines a research plan intent upon achieving health equity for all Floridians.

GRANTEE SPOTLIGHT: Developing New Treatments for the Most Deadly Type of Breast Cancer

Triple negative breast cancer affects some 30,000 women yearly in the U.S., with a predominant effect on young women and those of African descent, and is the most challenging type of breast cancer to treat.

GRANTEE SPOTLIGHT: King Grant Helps Florida State University Lab Move Discovery Closer to Patients

Dr. Michael Blaber, 2011 recipient of a King Program Technology Transfer Feasibility Grant at Florida State University, described his team’s work to deliver improved treatments to patients with ischemic disease - a condition where blood vessels do not provide enough blood flow to support healthy tissue.

GRANTEE SPOTLIGHT: Taking New Ovarian Cancer Test from Idea Stage to Prototype

Ovarian cancer is known as the silent killer due to lack of clear symptoms and the absence of a reliable screening test. More than 70 percent of women are diagnosed after the disease has spread beyond the ovary, and the five-year survival rate is less than 40 percent.

Miami 2012 Winter Symposium: Nanotechnology in Biomedicine

The University of Miami, Nature Publishing Group and Scripps Florida are pleased to announce the Miami 2012 Winter Symposium: Nanotechnology in Biomedicine. The symposium will be held February 26-29, 2012, at the JW Marriott Marquis Miami, Miami, FL.